Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2009 03:20 ET | Source: Evotec AG

Evotec Receives Milestone Payment From Boehringer Ingelheim

HAMBURG, Germany, July 29, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced that a further research milestone, leading to payments to Evotec, has been successfully...
July 14, 2009 03:06 ET | Source: Evotec AG

Evotec Announces Research Agreement On Fragment Based Screening Drug Discovery With Cubist Pharmaceuticals

HAMBURG, Germany and OXFORD, UK, July 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC), a leading provider in the discovery and development of novel small molecule drugs, today...
June 29, 2009 02:03 ET | Source: Evotec AG

Evotec Announces the Successful Completion of the First Phase I Study With EVT 401, An Oral P2X7 Receptor Antagonist -- Very Good Safety Profile and Confirmed 'On Target Activity'

HAMBURG, Germany, June 29, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced the successful completion of the first Phase I study with its P2X7 receptor antagonist EVT...
May 12, 2009 01:31 ET | Source: Evotec AG

Evotec Announces First Quarter Results and Corporate Development Update

HAMBURG, Germany, May 12, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported results and corporate development updates for the first quarter ended March 31,...
May 07, 2009 02:29 ET | Source: Evotec AG

Evotec Acquires Zebrafish Screening Operations of Summit Corporation

* Strong addition to Evotec's core business in drug discovery * Acquisition against GBP0.5 million cash in 2009 expected to add approximately GBP1.5 million revenues in 2010 * Additional...
May 06, 2009 09:17 ET | Source: Evotec AG

Evotec to Report First Quarter 2009 Results On May 12, 2009

HAMBURG, Germany, May 6, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) will report its financial results for the first quarter of 2009 on Tuesday, May 12, 2009. The Company is...
May 05, 2009 15:10 ET | Source: Evotec AG

Evotec to Re-Engineer Drug Discovery and Development Operations

-- Evotec to Concentrate All Proprietary Core Research Programs At Its European operations -- Leveraging World-Class Discovery Alliance Business Infrastructure Will Lead to a Minimum of...
April 27, 2009 01:54 ET | Source: Evotec AG

Walter Wenninger Nominated for Election as New Supervisory Board Member of Evotec

HAMBURG, Germany, April 27, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) announced today that the Supervisory Board proposes at the next Annual General Meeting to be held on June...
April 14, 2009 12:56 ET | Source: Evotec AG

Evotec Reports Results of Phase II Proof-of-Concept Study With EVT 302

HAMBURG, Germany, April 14, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today announced the results of a Phase II proof-of-concept study investigating the potential of EVT 302, a...
March 27, 2009 02:55 ET | Source: Evotec AG

Evotec Announces Financial Results for 2008

HAMBURG, Germany, March 27, 2009 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported financial results for the year ended December 31, 2008. Evotec revenues for the twelve...